FR2595351B1 - Derives d'indole, procede pour leur preparation et compositions pharmaceutiques les contenant - Google Patents

Derives d'indole, procede pour leur preparation et compositions pharmaceutiques les contenant

Info

Publication number
FR2595351B1
FR2595351B1 FR878700107A FR8700107A FR2595351B1 FR 2595351 B1 FR2595351 B1 FR 2595351B1 FR 878700107 A FR878700107 A FR 878700107A FR 8700107 A FR8700107 A FR 8700107A FR 2595351 B1 FR2595351 B1 FR 2595351B1
Authority
FR
France
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
indole derivatives
indole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR878700107A
Other languages
English (en)
French (fr)
Other versions
FR2595351A1 (fr
Inventor
Keith Mills
Colin David Eldred
Alexander William Oxford
Ian Harold Coates
David Edmund Bays
Colin Frederick Webb
Michael Dennis Dowle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FR2595351A1 publication Critical patent/FR2595351A1/fr
Application granted granted Critical
Publication of FR2595351B1 publication Critical patent/FR2595351B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR878700107A 1986-01-08 1987-01-08 Derives d'indole, procede pour leur preparation et compositions pharmaceutiques les contenant Expired - Fee Related FR2595351B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868600397A GB8600397D0 (en) 1986-01-08 1986-01-08 Chemical compounds

Publications (2)

Publication Number Publication Date
FR2595351A1 FR2595351A1 (fr) 1987-09-11
FR2595351B1 true FR2595351B1 (fr) 1990-07-13

Family

ID=10591074

Family Applications (1)

Application Number Title Priority Date Filing Date
FR878700107A Expired - Fee Related FR2595351B1 (fr) 1986-01-08 1987-01-08 Derives d'indole, procede pour leur preparation et compositions pharmaceutiques les contenant

Country Status (23)

Country Link
US (1) US4855314A (enExample)
EP (1) EP0240096A1 (enExample)
JP (1) JPS62228056A (enExample)
KR (1) KR870007116A (enExample)
CN (1) CN1030409A (enExample)
AU (1) AU597325B2 (enExample)
BE (1) BE1000071A4 (enExample)
CH (1) CH672637A5 (enExample)
DE (1) DE3700408A1 (enExample)
DK (1) DK8787A (enExample)
FI (1) FI870062A7 (enExample)
FR (1) FR2595351B1 (enExample)
GB (2) GB8600397D0 (enExample)
HU (1) HU198685B (enExample)
IL (1) IL81201A (enExample)
IT (1) IT1205849B (enExample)
LU (1) LU86732A1 (enExample)
NL (1) NL8700026A (enExample)
NO (1) NO870075L (enExample)
NZ (1) NZ218868A (enExample)
PH (1) PH24741A (enExample)
PT (1) PT84075B (enExample)
ZA (1) ZA87105B (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8530507D0 (en) * 1985-12-11 1986-01-22 Glaxo Group Plc Chemical compounds
GB8600398D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
GB8724912D0 (en) 1987-10-23 1987-11-25 Wellcome Found Indole derivatives
US5225431A (en) * 1987-10-23 1993-07-06 Burroughs Wellcome Co. Therapeutic substituted indole compounds and compositions thereof
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
GB8823731D0 (en) * 1988-10-10 1988-11-16 Smith Kline French Lab Biologically active compounds
MC2210A1 (fr) * 1990-06-07 1992-11-26 Wellcome Found Composes heterocycliques therapeutiques,leur utilisation et procede pour les preparer
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
ES2104733T3 (es) * 1990-10-15 1997-10-16 Pfizer Derivados de indol.
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
CA2061520C (en) * 1991-03-27 2003-04-22 Lawrence J. Daher Delivery system for enhanced onset and increased potency
ATE190608T1 (de) * 1991-11-25 2000-04-15 Pfizer 5-(hetero- oder carbocyclylamino)-indol derivate, deren herstellung und deren verwendung als 5-ht1 agonisten
TW288010B (enExample) * 1992-03-05 1996-10-11 Pfizer
UA27467C2 (uk) * 1992-04-07 2000-09-15 Пфайзер Інк. ПОХІДНІ ІНДОЛУ ЯК 5-НТ<sub>1</sub> АГОНІСТИ ТА ПРОМІЖНІ СПОЛУКИ
US6380233B1 (en) 1992-04-07 2002-04-30 Pfizer Inc Indole derivatives as 5-HT1 agonists
GB9207930D0 (en) * 1992-04-10 1992-05-27 Pfizer Ltd Indoles
CZ282653B6 (cs) * 1992-04-10 1997-08-13 Pfizer Inc. Acylaminoindolové deriváty představující 5-HT1 agonisty, způsob jejich přípravy, farmaceutické prostředky obsahující tyto látky, jejich použití a meziprodukty postupu přípravy
GB9211277D0 (en) 1992-05-28 1992-07-15 Glaxo Group Inc Pharmaceutical compositions
TW251284B (enExample) * 1992-11-02 1995-07-11 Pfizer
FR2707639B1 (fr) * 1993-06-30 1995-10-13 Pf Medicament Nouveaux composés indoliques dérivés d'arylamines comme ligands sélectifs des récepteurs 5HT1D et 5HT1B.
ES2070772B1 (es) * 1993-08-09 1996-02-16 Pfizer Derivados de acilaminoindol
DK0716649T3 (da) * 1993-08-31 1999-02-08 Pfizer 5-Arylindolderivater
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
GB9417310D0 (en) 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
FR2749846B1 (fr) * 1996-06-17 1998-09-11 Pf Medicament Sel de methanesulfonate d'une arylpiperazine derivee de tryptamine et ses solvates pour usage pharmaceutique
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
ES2266227T3 (es) * 2000-08-21 2007-03-01 Pacific Corporation Nuevos compuestos de (tio)urea y composiciones farmaceuticas que los contienen.
US7297711B2 (en) * 2002-06-21 2007-11-20 Suven Life Sciences Limited Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
EP1523486B1 (en) * 2002-06-21 2007-11-07 Suven Life Sciences Limited Tetracyclic arylsulfonyl indoles having serotonin receptor affinity
DE60309324T2 (de) 2002-06-21 2007-05-10 Suven Life Sciences Ltd. Tetracyclische arylcarbonyl indole mit serotoninrezeptoraffinität als arzneimittel, verfahren zu ihrer herstellung und pharmazeutische zubereitungen
BRPI0315958B8 (pt) 2002-11-28 2021-05-25 Suven Life Sciences Ltd composto, composição farmacêutica, processo para a preparação de um composto, novos intermediários e uso do composto
NZ540840A (en) * 2002-11-28 2008-12-24 Suven Life Sciences Ltd N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
SI1581538T1 (sl) * 2002-12-18 2007-08-31 Suven Life Sciences Ltd Tetraciklični 3-substituirani indoli z afiniteto za receptor serotonina
JP4897221B2 (ja) 2002-12-20 2012-03-14 チバ ホールディング インコーポレーテッド アミン類の合成及びその合成のための中間体
EP2032532B8 (en) * 2006-06-12 2015-07-01 Novartis AG Process for making salts of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3472870A (en) * 1966-08-29 1969-10-14 Mead Johnson & Co Sulfonamidotryptamines
FR2334358A1 (fr) * 1975-12-12 1977-07-08 Sogeras Nouveaux medicaments derives de l'indole
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds
GB2083463B (en) * 1980-08-12 1984-05-10 Glaxo Group Ltd Heterocyclic compounds
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
GB8332437D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB8332435D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB8332434D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Production of chemical compounds
GB8600398D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
PT84075B (pt) 1989-07-31
BE1000071A4 (fr) 1988-02-02
DK8787D0 (da) 1987-01-08
NL8700026A (nl) 1987-08-03
ZA87105B (en) 1987-09-30
AU6742087A (en) 1987-07-09
PH24741A (en) 1990-10-01
GB8700382D0 (en) 1987-02-11
HUT46891A (en) 1988-12-28
GB2185020B (en) 1990-05-16
DK8787A (da) 1987-07-09
AU597325B2 (en) 1990-05-31
FI870062A7 (fi) 1987-07-09
FI870062A0 (fi) 1987-01-08
IL81201A (en) 1991-06-10
PT84075A (en) 1987-02-01
NZ218868A (en) 1990-04-26
JPS62228056A (ja) 1987-10-06
DE3700408A1 (de) 1987-07-09
KR870007116A (ko) 1987-08-14
HU198685B (en) 1989-11-28
IT8747507A0 (it) 1987-01-08
FR2595351A1 (fr) 1987-09-11
IL81201A0 (en) 1987-08-31
CN1030409A (zh) 1989-01-18
LU86732A1 (fr) 1988-02-02
EP0240096A1 (en) 1987-10-07
GB8600397D0 (en) 1986-02-12
IT1205849B (it) 1989-03-31
CH672637A5 (enExample) 1989-12-15
NO870075L (no) 1987-07-09
NO870075D0 (no) 1987-01-08
US4855314A (en) 1989-08-08
GB2185020A (en) 1987-07-08

Similar Documents

Publication Publication Date Title
FR2595351B1 (fr) Derives d&#39;indole, procede pour leur preparation et compositions pharmaceutiques les contenant
BE896986A (fr) Derives d&#39;indole, procedes pour leur preparation et composition pharmaceutiques les contenant
FR2665898B1 (fr) Derives d&#39;amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2740136B1 (fr) Derives d&#39;indolin-2-one, procede pour leur preparation et les compositions pharmaceutiques les contenant
MA26439A1 (fr) Derives d&#39;indazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
PT78340B (fr) Procede de preparation de nouveaux derives de la tetrahydroxy- 3&#39;,4&#39;,5,7-flavone et des compositions pharmaceutiques les contenant
MA26438A1 (fr) Derives 6,5-heterobicycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26470A1 (fr) Derives de 1,3,8-triazaspiro (4,5) decane-4-one substitues en position 8, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation
FR2542740B1 (fr) Derives de thiazolidine, procede pour leur preparation et compositions pharmaceutiques les contenant
PT85279A (fr) Procede de preparation de derives du nitrofurane et de compositions pharmaceutiques les contenant
PT83896A (fr) Procede pour la preparation de nouveaux conjuges de la vinblas-tine et de ses derives et de compositions pharmaceutiques les contenant
FR2574793B1 (fr) Composes derives d&#39;indole, compositions pharmaceutiques les contenant et procede pour leur preparation
FR2728901B1 (fr) Derives de phenyl-4-thiazoles substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2599034B1 (fr) Derives de 1-(hydroxystyryl)-5h-2,3,-benzodiazepine, procede pour les preparer et compositions pharmaceutiques les contenant
FR2621587B1 (fr) Derives du dimethyl-2,2 chromene, procede pour leur preparation et composition pharmaceutiques les contenant
FR2600061B1 (fr) Derives d&#39;indole, composition pharmaceutique les contenant et procede pour leur preparation
FR2605004B1 (fr) Nouveaux derives d&#39;amino-acides, leur procede de preparation et composition pharmaceutiques les contenant
FR2557114B1 (fr) Nouveaux derives de la gonadoliberine, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2563519B1 (fr) Derives d&#39;iminothiazolidine, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2582835B1 (fr) Derives de la quinoleine, leur procede de preparation et compositions pharmaceutiques les contenant
BE885633A (fr) Derives de 1,2,4-oxadiazolin-5-one, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2529551B1 (fr) Derives d&#39;eburnane-oxime, procede pour leur preparation et compositions pharmaceutiques contenant ces composes
FR2615188B1 (fr) Derives d&#39;hydrazine, procede d&#39;obtention et compositions pharmaceutiques les contenant
FR2603587B1 (fr) Derives de la 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxazonine (ou -1,4-benzoxazonine), procede pour leur preparation, medicaments les contenant et composes intermediaires
FR2622194B1 (fr) Nouveaux derives de la 19-nor progesterone, leur procede d&#39;obtention et les compositions pharmaceutiques en contenant

Legal Events

Date Code Title Description
ST Notification of lapse